Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0LE1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,522
Award facts
- Contract value 100% obligated
- $16,521.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,521.56 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pen injections on December 2, 2025, with completion scheduled for December 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive portfolio of medications and medical supplies to support military and veteran healthcare systems.
The delivery order for Zepbound, a diabetes medication, exemplifies the breadth of pharmaceutical products distributed through AmerisourceBergen's federal contracts, which span specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Through its comprehensive IDC vehicle, the company supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As DLA Troop Support prepares to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, AmerisourceBergen's demonstrated capability in fulfilling diverse federal medical supply requirements positions it as a key vendor within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F0LE1?
SPE2DR26F0LE1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F0LE1 worth?
The government has obligated $16,522 on SPE2DR26F0LE1.
Is contract SPE2DR26F0LE1 an order under another contract?
Yes. SPE2DR26F0LE1 is a delivery order under SPE2DR25D3007, an indefinite delivery contract.
Was contract SPE2DR26F0LE1 competed?
The extent of competition for SPE2DR26F0LE1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award